Search research articles
Contact Us
Filters
Showing results (191-200 of 1,012) with videos related to
Page
of 102
Sort By:
The Journal of Nutrition
|
November 11, 2003
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
Kirsten B Holven, Hanne Scholz, Bente Halvorsen, et al.
European Journal of Clinical Investigation
|
June 20, 2003
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
K B Holven, B Halvorsen, H Schulz, et al.
International Journal of Cardiology
|
August 9, 2006
The role of intravenous immunoglobulin in the treatment of chronic heart failure
Pål Aukrust, Arne Yndestad, Thor Ueland, et al.
Journal of Molecular Biology
|
March 31, 2007
The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV
Ingvild Aukrust, Hanne Hollås, Elin Strand, et al.
The Laryngoscope
|
October 18, 2018
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis
Johan Steineger, Thor Ueland, Pål Aukrust, et al.
Scientific Reports
|
August 26, 2018
The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α
Alba Kaci, Magdalena Keindl, Marie H Solheim, et al.
Frontiers in Immunology
|
May 7, 2024
Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: a pilot study
Mahtab Zamani, Karolina Skagen, Beate Lindberg, et al.
Coronary Artery Disease
|
January 20, 2025
Clinical outcomes and patients' perspective of fatigue following spontaneous coronary artery dissection
Sahrai Saeed, Erlend Eriksen, Pål Aukrust, et al.
FEBS Letters
|
December 29, 2004
Ubiquitinated annexin A2 is enriched in the cytoskeleton fraction
Silje U Lauvrak, Hanne Hollås, Anne P Døskeland, et al.
Autoimmunity
|
December 29, 2004
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody
Lisa Larsson, Reza Mobini, Pål Aukrust, et al.
Page
of 102
Search research articles
Search
Showing results (191-200 of 1,012) with videos related to
Sort By:
Page
of 102
The Journal of Nutrition
|
November 11, 2003
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
Kirsten B Holven, Hanne Scholz, Bente Halvorsen, et al.
European Journal of Clinical Investigation
|
June 20, 2003
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
K B Holven, B Halvorsen, H Schulz, et al.
International Journal of Cardiology
|
August 9, 2006
The role of intravenous immunoglobulin in the treatment of chronic heart failure
Pål Aukrust, Arne Yndestad, Thor Ueland, et al.
Journal of Molecular Biology
|
March 31, 2007
The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV
Ingvild Aukrust, Hanne Hollås, Elin Strand, et al.
The Laryngoscope
|
October 18, 2018
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis
Johan Steineger, Thor Ueland, Pål Aukrust, et al.
Scientific Reports
|
August 26, 2018
The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α
Alba Kaci, Magdalena Keindl, Marie H Solheim, et al.
Frontiers in Immunology
|
May 7, 2024
Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: a pilot study
Mahtab Zamani, Karolina Skagen, Beate Lindberg, et al.
Coronary Artery Disease
|
January 20, 2025
Clinical outcomes and patients' perspective of fatigue following spontaneous coronary artery dissection
Sahrai Saeed, Erlend Eriksen, Pål Aukrust, et al.
FEBS Letters
|
December 29, 2004
Ubiquitinated annexin A2 is enriched in the cytoskeleton fraction
Silje U Lauvrak, Hanne Hollås, Anne P Døskeland, et al.
Autoimmunity
|
December 29, 2004
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody
Lisa Larsson, Reza Mobini, Pål Aukrust, et al.
Page
of 102